Metraipolis › archive › dc_4e800df1cb4b

Peripheral lymphocyte count as a prognostic marker in cervical cancer patients treated with immune checkpoint inhibitors: a retrospective study — Europe PMC PMID:41225450

Source: Europe PMC (en)
Original: https://europepmc.org/article/MED/41225450
DOI: 10.1186/s12885-[numero omesso]-x
License (as archived): solo-consultazione
Archived: 2026-11-08T15:05:11.351Z
SHA-256 of the archived text: 1ddb665545bf7bd80d80c1fd21f289ba1adcda627fe0e1a5bead4e5a96f32ee8
Stable URL of this page: https://metraipolis.com/documento/dc_4e800df1cb4b

How to cite

Peripheral lymphocyte count as a prognostic marker in cervical cancer patients treated with immune checkpoint inhibitors: a retrospective study — Europe PMC PMID:41225450 — Europe PMC (en), https://europepmc.org/article/MED/41225450 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_4e800df1cb4b (Metraipolis archive dc_4e800df1cb4b, sha256 1ddb665545bf7bd80d80c1fd21f289ba1adcda627fe0e1a5bead4e5a96f32ee8)

BibTeX

@misc{dc4e800df1cb4b,
  title = {Peripheral lymphocyte count as a prognostic marker in cervical cancer patients treated with immune checkpoint inhibitors: a retrospective study — Europe PMC PMID:41225450},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41225450},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_4e800df1cb4b; sha256 1ddb665545bf7bd80d80c1fd21f289ba1adcda627fe0e1a5bead4e5a96f32ee8},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41225450. Agents can read the archived copy with the MCP tool read_document.